المؤلفون: Larkin, J, Del Vecchio, M, Mandala, M, Gogas, H, Arance, AM, Dalle, S, Cowey, CL, Schenker, M, Grob, J-J, Chiarion-Sileni, V, Marquez-Rodas, I, Butler, MO, Di Giacomo, AM, Middleton, MR, Lutzky, J, de la Cruz-Merino, L, Arenberger, P, Atkinson, V, Hill, AG, Fecher, LA, Millward, M, Nathan, PD, Khushalani, NI, Queirolo, P, Ritchings, C, Lobo, M, Askelson, M, Tang, H, Dolfi, S, Ascierto, PA, Weber, J

المساهمون: Larkin, James

جغرافية الموضوع: United States

وصف الملف: Print-Electronic; CCR-22-3145 -; application/pdf

العلاقة: 725906; Clinical Cancer Research, 2023, pp. CCR-22-3145 -; https://repository.icr.ac.uk/handle/internal/5881Test

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-22-3145Test
https://repository.icr.ac.uk/handle/internal/5881Test

المؤلفون: Mandala, M, Larkin, J, Ascierto, PA, Del Vecchio, M, Gogas, H, Cowey, CL, Arance, A, Dalle, S, Schenker, M, Grob, J-J, Chiarion-Sileni, V, Marquez-Rodas, I, Butler, MO, Di Giacomo, AM, Lutzky, J, De La Cruz-Merino, L, Atkinson, V, Arenberger, P, Hill, A, Fecher, L, Millward, M, Khushalani, NI, de Pril, V, Lobo, M, Weber, J

المساهمون: Larkin, James

مصطلحات موضوعية: adjuvants, immunologic, immunotherapy, melanoma, programmed cell death 1 receptor, Aged, Disease-Free Survival, Female, Humans, Immune Checkpoint Inhibitors, Neoplasm Staging, Nivolumab, Treatment Outcome

جغرافية الموضوع: England

وصف الملف: Print; application/pdf

العلاقة: ARTN e003188; jitc-2021-003188; Journal for ImmunoTherapy of Cancer, 2021, 9 (8), pp. e003188 -; https://repository.icr.ac.uk/handle/internal/5285Test

الإتاحة: https://doi.org/10.1136/jitc-2021-003188Test
https://repository.icr.ac.uk/handle/internal/5285Test

المؤلفون: Mandala M., Larkin J., Ascierto P. A., Del Vecchio M., Gogas H., Cowey C. L., Arance A., Dalle S., Schenker M., Grob J. -J., Chiarion-Sileni V., Marquez I., Butler M. O., Di Giacomo A. M., Lutzky J., De La Cruz-Merino L., Atkinson V., Arenberger P., Hill A., Fecher L., Millward M., Khushalani N. I., De Pril V., Lobo M., Weber J.

المساهمون: Mandala, M., Larkin, J., Ascierto, P. A., Del Vecchio, M., Gogas, H., Cowey, C. L., Arance, A., Dalle, S., Schenker, M., Grob, J. -J., Chiarion-Sileni, V., Marquez, I., Butler, M. O., Di Giacomo, A. M., Lutzky, J., De La Cruz-Merino, L., Atkinson, V., Arenberger, P., Hill, A., Fecher, L., Millward, M., Khushalani, N. I., De Pril, V., Lobo, M., Weber, J.

مصطلحات موضوعية: adjuvant, immunologic, immunotherapy, melanoma, programmed cell death 1 receptor

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34452930; info:eu-repo/semantics/altIdentifier/wos/WOS:000691920700003; volume:9; issue:8; firstpage:1; lastpage:9; numberofpages:9; journal:JOURNAL FOR IMMUNOTHERAPY OF CANCER; https://hdl.handle.net/11365/1233242Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85114247620; https://jitc.bmj.com/content/9/8/e003188Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404438Test/

الإتاحة: https://doi.org/10.1136/jitc-2021-003188Test
https://hdl.handle.net/11365/1233242Test
https://jitc.bmj.com/content/9/8/e003188Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404438Test/

المؤلفون: Sarnaik, A. (Amod), Hamid, O. (Omid), Khushalani, N. (Nikhil), Lewis, K. (Karl), Medina, T. (Theresa), Kluger, H. (Harriet), Thomas, S. (Sajeve), Domingo-Musibay, E. (Evidio), Pavlick, A. (Anna), Whitman, E. (Eric), Martin-Algarra, S. (Salvador), Corrie, P. (Pippa), Curti, B. (Brendan), Olah, J. (Judit), Lutzky, J. (Jose), Qin, H. (Harry), Wu, X. (Xiao), Chartier, C. (Cecile), Graf-Finckenstein, F. (Friedrich), Fardis, M. (Maria), Kirkwood, J.M. (John M.), Chesney, J. (Jason)

مصطلحات موضوعية: Metastatic, Unresectable, Melanoma, Immune checkpoint inhibitors

وصف الملف: application/pdf

العلاقة: https://hdl.handle.net/10171/68514Test

الإتاحة: https://hdl.handle.net/10171/68514Test

المؤلفون: Haydon, A, Alamgeer, M, Brungs, D, Collichio, F, Khushalani, N, Colevas, D, Rischin, D, Kudchadkar, R, Chai-Ho, W, Daniels, G, Lutzky, J, Lee, J, Bowyer, S, Migden, M, Silk, A, Lebbe, C, Grob, J-J, Melero, I, Sheladia, P, Bommareddy, P, He, S, Andreu-Vieyra, C, Fury, M, Hill, A

العلاقة: Haydon, A., Alamgeer, M., Brungs, D., Collichio, F., Khushalani, N., Colevas, D., Rischin, D., Kudchadkar, R., Chai-Ho, W., Daniels, G., Lutzky, J., Lee, J., Bowyer, S., Migden, M., Silk, A., Lebbe, C., Grob, J. -J., Melero, I., Sheladia, P. ,. Hill, A. (2021). CERPASS: A RANDOMIZED, CONTROLLED, OPEN-LABEL, PHASE 2 STUDY OF CEMIPLIMAB +/- RP1 IN PATIENTS WITH ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA. [Abstract]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 9 (Suppl 2), https://doi.org/10.1136/jitc-2021-SITC2021.547Test.; http://hdl.handle.net/11343/301708Test

الإتاحة: https://doi.org/10.1136/jitc-2021-SITC2021.547Test
http://hdl.handle.net/11343/301708Test

المؤلفون: Sarnaik, AA, Hamid, O, Khushalani, NI, Lewis, KD, Medina, T, Kluger, HM, Thomas, SS, Domingo-Musibay, E, Pavlick, AC, Whitman, ED, Martin-Algarra, S, Corrie, P, Curti, BD, Oláh, J, Lutzky, J, Weber, JS, Larkin, JMG, Shi, W, Takamura, T, Jagasia, M, Qin, H, Wu, X, Chartier, C, Graf Finckenstein, F, Fardis, M, Kirkwood, JM, Chesney, JA

المساهمون: Larkin, James

وصف الملف: Print-Electronic; ?; application/pdf

العلاقة: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, pp. JCO2100612 - ?; https://repository.icr.ac.uk/handle/internal/4564Test

الإتاحة: https://doi.org/10.1200/jco.21.00612Test
https://repository.icr.ac.uk/handle/internal/4564Test

المؤلفون: Haydon, A.M., Alamgeer, M., Brungs, D., Collichio, F., Khushalani, N.I., Colevas, A.D., Rischin, D., Kudchadkar, R., Chai-Ho, W., Daniels, G., Lutzky, J., Lee, J.H., Bowyer, S., Migden, M.R., Sheladia, P., Bommareddy, P.K., He, S., Andreu-Vieyra, C., Fury, M.G., Hill, A.

المصدر: Annals of Oncology ; volume 32, page S904 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016Test/j.annonc.2021.08.1479
https://api.elsevier.com/content/article/PII:S092375342103708X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342103708X?httpAccept=text/plainTest

المؤلفون: Antonia S, Balmanoukian A, Brahmer J, Ou S-H, Hellmann M, Kim S-W, Ahn M-J, Kim D-W, Gutierrez M, Liu S, Schöffski P, Jäger D, Jamal R, Jerusalem G, Lutzky J, Nemunaitis J, CalabrO' L, Weiss J, Gadgeel S, Bhosle J, Ascierto P, Rebelatto M, Narwal R, Liang M, Xiao F, Antal J, Abdullah S, Angra N, Gupta AK, Khleif SN, Segal NH

المساهمون: Antonia, S, Balmanoukian, A, Brahmer, J, Ou, S-H, Hellmann, M, Kim, S-W, Ahn, M-J, Kim, D-W, Gutierrez, M, Liu, S, Schöffski, P, Jäger, D, Jamal, R, Jerusalem, G, Lutzky, J, Nemunaitis, J, Calabro', L, Weiss, J, Gadgeel, S, Bhosle, J, Ascierto, P, Rebelatto, M, Narwal, R, Liang, M, Xiao, F, Antal, J, Abdullah, S, Angra, N, Gupta, Ak, Khleif, Sn, Segal, Nh

مصطلحات موضوعية: Durvalumab, Efficacy, Immunotherapy, NSCLC, Safety

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31228626; info:eu-repo/semantics/altIdentifier/wos/WOS:000487254200030; volume:14; issue:10; firstpage:1794; lastpage:1806; numberofpages:13; journal:JOURNAL OF THORACIC ONCOLOGY; https://hdl.handle.net/11392/2492559Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85071622278; https://www.jto.org/action/showPdf?pii=S1556-0864Test(19)30475-7; https://www.jto.org/article/S1556-0864Test(19)30475-7/fulltext

الإتاحة: https://doi.org/10.1016Test/j.jtho.2019.06.010
https://hdl.handle.net/11392/2492559Test
https://www.jto.org/action/showPdf?pii=S1556-0864Test(19)30475-7
https://www.jto.org/article/S1556-0864Test(19)30475-7/fulltext

المؤلفون: Mateos M. -V., Blacklock H., Schjesvold F., Oriol A., Simpson D., George A., Goldschmidt H., Larocca A., Chanan-Khan A., Sherbenou D., Avivi I., Benyamini N., Iida S., Matsumoto M., Suzuki K., Ribrag V., Usmani S. Z., Jagannath S., Ocio E. M., Rodriguez-Otero P., San Miguel J., Kher U., Farooqui M., Liao J., Marinello P., Lonial S., Nicol A., Grigoriadis G., Catalano J., LeBlanc R., Elemary M., Bahlis N., Facon T., Karlin L., Attal M., Engelhardt M., Weisel K., Mackensen A., Nagler A., Ben Yehuda D., Magen-Nativ H., Palumbo A., Cavo M., Tobinai K., Chou T., Kosugi H., Taniwaki M., Sunami K., Ando K., Ganly P., Gjertsen B., Lahuerta J., Blade J., Oriol Rocafiguera A., Mateos M., Larson S., Atanackovic D., Devarakonda S., Bitran J., Zonder J., Morganstein N., Hay M., Saylors G., Kio E., Oliff I., Kirkel D., Shtivelband M., Yuen C., Yee A., Shah J., Htut M., Raza S., Chhabra S., Stiff P., Hari P., Bank B., Malek E., Gasparetto C., Faroun Y., Kreisle W., Singhal S., Rosenblatt J., Usmani S., Lee W., Safah H., Lutzky J., Suh J., Pan D., Baron A., Manges R., Steis R., Oliveira M., Moreb J., Callander N., Anz B., Raptis A., Stampleman L., Melear J., Boyd T., Garbo L., Klein L., Shao S., Lyons R., McIntyre K., Tarantolo S., Yasenchak C., Yimer H.

المساهمون: Mateos M.-V., Blacklock H., Schjesvold F., Oriol A., Simpson D., George A., Goldschmidt H., Larocca A., Chanan-Khan A., Sherbenou D., Avivi I., Benyamini N., Iida S., Matsumoto M., Suzuki K., Ribrag V., Usmani S.Z., Jagannath S., Ocio E.M., Rodriguez-Otero P., San Miguel J., Kher U., Farooqui M., Liao J., Marinello P., Lonial S., Nicol A., Grigoriadis G., Catalano J., LeBlanc R., Elemary M., Bahlis N., Facon T., Karlin L., Attal M., Engelhardt M., Weisel K., Mackensen A., Nagler A., Ben Yehuda D., Magen-Nativ H., Palumbo A., Cavo M., Tobinai K., Chou T., Kosugi H., Taniwaki M., Sunami K., Ando K., Ganly P., Gjertsen B., Lahuerta J., Blade J., Oriol Rocafiguera A., Mateos M., Larson S., Atanackovic D., Devarakonda S., Bitran J., Zonder J., Morganstein N., Hay M., Saylors G., Kio E., Oliff I., Kirkel D., Shtivelband M., Yuen C., Yee A., Shah J., Htut M., Raza S., Chhabra S., Stiff P., Hari P., Bank B., Malek E., Gasparetto C., Faroun Y., Kreisle W., Singhal S., Rosenblatt J., Usmani S., Lee W., Safah H., Lutzky J., Suh J., Pan D., Baron A., Manges R., Steis R., Oliveira M., Moreb J., Callander N., Anz B., Raptis A., Stampleman L., Melear J., Boyd T., Garbo L.

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31327687; info:eu-repo/semantics/altIdentifier/wos/WOS:000483400400009; volume:6; issue:9; firstpage:e459; lastpage:e469; numberofpages:11; journal:THE LANCET. HAEMATOLOGY; https://hdl.handle.net/2318/1742132Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85071223893; https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026Test(19)30110-3/fulltext; https://doi.org/10.1016/s2352-3026Test(19)30110-3

الإتاحة: https://doi.org/10.1016/S2352-3026Test(19)30110-3
https://doi.org/10.1016/s2352-3026Test(19)30110-3
https://hdl.handle.net/2318/1742132Test
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026Test(19)30110-3/fulltext

المؤلفون: Sarnaik, A. (Amod), Khushalani, N. (Nikhil), Chesney, J. (Jason), Kluger, H. (Harriet), Curti, B. (Brendan), Lewis, K. (Karl), Medina, T. (Theresa), Thomas, S. (Sajeve), Pavlick, A. (Anna), Whitman, E. (Eric), Martin-Algarra, S. (Salvador), Corrie, P. (Pippa), Hamid, O. (Omid), Lutzky, J. (Jose), Olah, J. (Judit), Weber, J.S. (Jeffrey S.), Larkin, J. (James), Shi, W. (Wen), DiTrapani, K. (Kelly), Qin, H. (Harry), Mirgoli, M. (Mariam), Wu, R. (Renee), Takamura, T. (Toshimi), Fardis, M. (Maria), Kirkwood, J.M. (John M.)

مصطلحات موضوعية: Treatment options, Advanced melanoma, Inhibitors, Cell therapy

وصف الملف: application/pdf

العلاقة: https://hdl.handle.net/10171/66224Test

الإتاحة: https://hdl.handle.net/10171/66224Test